MedPath

广东希埃医药有限公司

Ownership
-
Established
1996-04-04
Employees
-
Market Cap
-
Website
www.guangdongci.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

10

NMPA:10

Drug Approvals

Technetium [99mTc] Methylenediphosphonate Injection

Product Name
锝[99mTc]亚甲基二膦酸盐注射液
Approval Number
国药准字H10973014
Approval Date
Jul 1, 2022
NMPA

Technetium[99mTc] Phytate Injection

Product Name
锝[99mTc]植酸盐注射液
Approval Number
国药准字H10973016
Approval Date
Jul 1, 2022
NMPA

Technetium[99mTc] Pentetate Injection

Product Name
锝[99mTc]喷替酸盐注射液
Approval Number
国药准字H10973012
Approval Date
Jul 1, 2022
NMPA

Technetium[99mTc] Albumin Aggregated Injection

Product Name
锝[99mTc]聚合白蛋白注射液
Approval Number
国药准字H10973011
Approval Date
Jul 1, 2022
NMPA

Technetium[99mTc] L,L-Ethylenedicysteine Injection

Product Name
锝[99mTc]双半胱氨酸注射液
Approval Number
国药准字H10973069
Approval Date
Jul 1, 2022
NMPA

Technetium[99mTc] Bicisate Injection

Product Name
锝[99mTc]双半胱乙酯注射液
Approval Number
国药准字H10973013
Approval Date
Jul 1, 2022
NMPA

Technetium[99mTc] Etifenin Injection

Product Name
锝[99mTc]依替菲宁注射液
Approval Number
国药准字H10973015
Approval Date
Jul 1, 2022
NMPA

Technetium[99mTc] Succimer Injection

Product Name
锝[99mTc]二巯丁二酸盐注射液
Approval Number
国药准字H10973067
Approval Date
Jul 1, 2022
NMPA

Technetium[99mTc] Sestamibi Injection

Product Name
锝[99mTc]甲氧异腈注射液
Approval Number
国药准字H10973068
Approval Date
Jul 1, 2022
NMPA

Sodium Pertechnetate [99mTc] Injection

Product Name
高锝[99mTc]酸钠注射液
Approval Number
国药准字H10973010
Approval Date
Jul 1, 2022
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.